Neuroprotection of Creatine Supplementation in Neonatal Rats with Transient Cerebral Hypoxia-Ischemia
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
We hypothesized that creatine (Cr) supplementation would preserve energy metabolism and thus ameliorate the energy failure and the extent of brain edema seen after severe but transient cerebral hypoxia-ischemia (HI) in the neonatal rat model. Six-day-old (P6) rats received subcutaneous Cr monohydrate injections for 3 consecutive days (3 g/kg body weight/day), followed by 31 P-magnetic resonance spectroscopy (MRS) at P9. In a second group, P4 rats received the same Cr dose as above for 3 days prior to unilateral common carotid artery ligation followed 1 h later by 100 min of hypoxia (8% O 2) at P7. Rats were maintained at 37°C rectal temperature until magnetic resonance imaging was performed 24 h after HI. Cr supplementation for 3 days significantly increased the energy potential, i.e. the ratio of phosphocreatine to β-nucleotide triphosphate (PCr/βNTP) and PCr/inorganic phosphate (PCr/Pi) as measured by 31 P-MRS. Rats with hemispheric cerebral hypoxic-ischemic insult that had received Cr showed a significant reduction (25%) of the volume of edemic brain tissue compared with controls as calculated from diffusion-weighted images (DWI). Thus, prophylactic Cr supplementation demonstrated a significant neuroprotective effect 24 h after transient cerebral HI. We hypothesize that neuroprotection is probably due to the availability of a larger metabolic substrate pool leading to a reduction of the secondary energy failure because DWI has been reported to correlate with the PCr/Pi ratio in the acute phase of injury. Additional protection by Cr may be related to prevention of calcium overload, prevention of mitochondrial permeability transition pore opening and direct antioxidant effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The authors concluded that creatine supplementation appears to improve brain bioenergetics thereby helping minimize the impact of brain ischemia.”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [140]
In the citing paper
“there is evidence from animal models that creatine supplementation is neuroprotective [147–149] and can reduce the severity of spinal cord injury [150, 151], cerebral ischemia [152–155], and concussion/traumatic brain injury [2, 7, 12, 22, 32, 33, 156].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [153]
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
The influence of immaturity on hypoxic‐ischemic brain damage in the rat
Rice, J. E., Vannucci, R. C., & Brierley, J. B. (1981) · Annals of Neurology · doi:10.1002/ana.410090206 · Cited by 2,134
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,081
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Anoxic-ischemic encephalopathy in rats.
LEVINE, S. (1960) · PubMed · Cited by 634
Lorek, A., Takei, Y., Cady, E. B., Wyatt, J. S., Penrice, J., Edwards, A. D., Peebles, D., Wylezinska, M., Owen-Reece, H., Kirkbride, V, et al. (1994) · Pediatric Research · doi:10.1203/00006450-199412000-00003 · Cited by 561
Interventions for Perinatal Hypoxic–Ischemic Encephalopathy
Vannucci, R. C., & Perlman, J. M. (1997) · Pediatrics · doi:10.1542/peds.100.6.1004 · Cited by 464
Direct antioxidant properties of creatine
Lawler, J. M., Barnes, W. S., Wu, G., Song, W., & Demaree, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6164 · Cited by 448
Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R., & Beal, M. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 430
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“[140] reported that neonatal rats fed 3 g/ kg of creatine for 3 days observed a significant increase in the ratio of brain PCr to Pi and a 25% reduction in the volume of edemic brain tissue following cerebral hypoxic ischemia.”
BackgroundThe creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
“This corroborates earlier findings that Cr protects the brain of newborn rats against hypoxia (Adcock et al. 2002) or of adult mice in a model of stroke (Prass et al.”
BackgroundResultSelf-citationMitochondrial creatine kinase in human health and disease
Schlattner, U., Tokarska-Schlattner, M., & Wallimann, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.004 · Cited by 622
“Supportive to a role of the CK system in these disorders is the protective effect of creatine supplementation that has been observed in several studies, including human Duchenne muscular dystrophy [194–196], mitochondrial cytopathies [197], myophosphorylase deficiency [198], and in animal models of amyotrophic lateral…”
Self-citationFunctions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
“Neuroprotective effects of Cr supplementation have also been reported in animal models of ischemia [1,113].”
BackgroundSelf-citationAntonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Tolias, C. M., Reinert, M., Seiler, R., Gilman, C., Scharf, A., & Bullock, M. R. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.101.3.0435 · Cited by 257
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“For example, Adcock and associates [258] prophylactically administered neonatal rats creatine (3 g/kg for 3 days) and assessed brain bioenergetics in response to a cerebral ischemic event.”
BackgroundTarnopolsky, M. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.05.001 · Cited by 174
Exploring the therapeutic role of creatine supplementation
Gualano, B., Artioli, G. G., Poortmans, J. R., & Lancha Junior, A. H. (2010) · Amino Acids · doi:10.1007/s00726-009-0263-6 · Cited by 156
“Interestingly, a body of literature indicates that energetic disturbances induced by ischemia, cerebral vascular stroke, spinal cord injury, and cerebral trauma might be attenuated by Cr treatment (Adcock et al. 2002; Lensman et al. 2006; Ozkan et al. 2005; Scheff and Dhillon 2004).”
BackgroundBürklen, T. S., Schlattner, U., Homayouni, R., Gough, K., Rak, M., Szeghalmi, A., & Wallimann, T. (2006) · BioMed Research International · doi:10.1155/jbb/2006/35936 · Cited by 116
Self-citationMitochondrial contact sites: their role in energy metabolism and apoptosis
Brdiczka, D. G., Zorov, D. B., & Sheu, S.-S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.007 · Cited by 150
“In some disorders where defects in mitochondrial bioenergetics are detected a protective effect of creatine supplementation has been observed such as Duchenne muscular dystrophy [113–115], mitochondrial cytopathies [116], and in animal models of amyotrophic lateral sclerosis [117–119], Huntington’s disease [120,121],…”
BackgroundRobertson, C. L., Scafidi, S., McKenna, M. C., & Fiskum, G. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.030 · Cited by 143
“For instance, pretreatment of rats with creatine was reported to improve the cerebral phosphocreatine/phosphate ratio and reduce brain edema after neonatal hypoxic ischemia (Adcock et al., 2002).”
AltitudeOmics: Red Blood Cell Metabolic Adaptation to High Altitude Hypoxia
D’Alessandro, A., Nemkov, T. G., Sun, K., Liu, H., Song, A., Monte, A. A., Subudhi, A. W., Lovering, A. T., Dvorkin, D., Julian, C. G., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00733 · Cited by 145
Bolaños, J. P., Moro, M. Á., Lizasoaín, I., & Almeida, Á. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.009 · Cited by 140
Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
Prass, K., Royl, G., Lindauer, U., Freyer, D., Megow, D., Dirnagl, U., Stöckler-Ipsiroglu, G., Wallimann, T., & Priller, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600351 · Cited by 128
“Creatine protected neurons from anoxia in vitro (Carter et al, 1995; Parodi et al, 2003) and from hypoxia–ischemia in neonatal rat brain (Adcock et al, 2002).”
BackgroundSelf-citationCreatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112
“…was also demonstrated to exert neuroprotective effects, both in vitro and in vivo, against anoxic and ischemic damage (Balestrino et al. 2002; Adcock et al. 2002; Lensman et al. 2006) as well as against traumatic brain injury (Sullivan et al. 2000) and spinal cord injury (Hausmann et al.…”
BackgroundCognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
“Creatine supplementation presented significant neuroprotector effects in an animal model of transient cerebral ischemia [249].”
BackgroundCreatine Metabolism in Female Reproduction, Pregnancy and Newborn Health
Muccini, A. M., Tran, N. T., de Guingand, D. L., Philip, M., Della Gatta, P. A., Galinsky, R., Sherman, L. S., Kelleher, M. A., Palmer, K. R., Berry, M. J., et al. (2021) · Nutrients · doi:10.3390/nu13020490 · Cited by 78
Wallimann, T., Tokarska‐Schlattner, M., Neumann, D., Epand, R. M., Epand, R. F., Andres, R. H., Widmer, H. R., Hornemann, T., Saks, V., Agarkova, I., et al. (2007) · Molecular System Bioenergetics · doi:10.1002/9783527621095.ch7 · Cited by 80
Self-citationJain, V., Baitharu, I., Prasad, D., & Ilavazhagan, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062235 · Cited by 86
“However antioxidant supplementation showed limited neuroprotection in hypoxic and ischemic conditions which indicates involvement of other complex mechanisms that might lead to triggering of survival machinery of the cell [5].”
BackgroundRetractedMetabolic Alterations in Developing Brain After Injury: Knowns and Unknowns
McKenna, M. C., Scafidi, S., & Robertson, C. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1600-7 · Cited by 88
Wallimann, T., Riek, U., & Möddel, M. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2016.12.002 · Cited by 87
“Cr and PCr protect the heart and brain from ischemic insults and ROS-meditated reperfusion damage, both in vitro and in vivo [68,108]; and these protective effects of Cr and PCr probably extend to the kidney.”
BackgroundSelf-citationIreland, Z., Dickinson, H., Snow, R. J., & Walker, D. W. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.790 · Cited by 87
Andres, R. H., Huber, A. W., Schlattner, U., Pérez-Bouza, A., Krebs, S. H., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.004 · Cited by 86
Self-citationCreatine kinase in ischemic and inflammatory disorders
Kitzenberg, D., Colgan, S. P., & Glover, L. E. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0114-5 · Cited by 73
“Initial studies of Cr-elicited protection in neonatal hypoxic/reperfusion injury focused on rodent fetal brain slices [65, 66] and neonatal rats [67].”
BackgroundFleiss, B., Wong, F., Brownfoot, F., Shearer, I. K., Baud, O., Walker, D. W., Gressens, P., & Tolcos, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00188 · Cited by 74
“Supporting data include a number of pre-clinical studies(Adcock et al., 2002;Ireland et al., 2008;Ireland et al., 2011).”
BackgroundA review of creatine supplementation in age-related diseases: more than a supplement for athletes
Smith, R. N., Agharkar, A. S., & Gonzales, E. B. (2014) · F1000Research · doi:10.12688/f1000research.5218.1 · Cited by 82
“%) in the volume of edematous brain tissue compared when compared to control 131 .”
ResultSantacruz, L., Arciniegas, A. J. L., Darrabie, M. D., Mantilla, J. G., Baron, R. M., Bowles, D. E., Mishra, R., & Jacobs, D. O. (2017) · Physiological Reports · doi:10.14814/phy2.13382 · Cited by 82
“As mentioned previously, Cr supplementation has been reported to have a protective effect in both neurons, myoblasts, and cardiomyocytes in culture when subjected to hypoxic and increased oxidative stressors (Balestrino et al. 1999, 2002; Adcock et al. 2002; Caretti et al. 2010; Sartini et al. 2012).”
BackgroundCreatine for women in pregnancy for neuroprotection of the fetus
Dickinson, H., Bain, E., Wilkinson, D., Middleton, P., Crowther, C. A., & Walker, D. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010846.pub2 · Cited by 72
Creatine Supplementation Does not Reduce Muscle Damage or Enhance Recovery From Resistance Exercise
Rawson, E. S., Conti, M. P., & Miles, M. P. (2007) · The Journal of Strength and Conditioning Research · doi:10.1519/r-21076.1 · Cited by 57
Creatine and Creatine Kinase in Health and Disease
Salomons, G. S., & Wyss, M. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-6486-9 · Cited by 75
Ireland, Z., Castillo-Melendez, M., Dickinson, H., Snow, R., & Walker, D. W. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.012 · Cited by 74
“Previous studies have shown neuroprotective properties of creatine in neonatal rats and rabbits, although the creatine pre-treatment and hypoxia-ischemia were both applied more acutely and in the postnatal period (Holtzman et al., 1998, 1999; Adcock et al., 2002; Berger et al., 2004).”
Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Tarnopolsky, M. A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_10 · Cited by 67
“A number of studies have demonstrated that CrM supplementation can lead to a reduction in markers of oxidative stress in a variety of tissues, especially the central nervous system (Adcock et al., 2002; Andreassen et al., 2001; Klivenyi et al., 1999, 2004; Lawler et al., 2002; Malcon et al., 2000; Sullivan et al., 200…”
BackgroundAndres, R. H., Ducray, A. D., Pérez-Bouza, A., Schlattner, U., Huber, A. W., Krebs, S. H., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005) · Cell Transplantation · doi:10.3727/000000005783982756 · Cited by 59
Self-citationThe Neuroprotective Role of Creatine
Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 63
“The creatine-treated rats showed a significant reduction in volume of brain edema and an increased ‘energy potential’ as reflected by the ratio of PCr to inorganic phosphate that was measured by 31P-magnetic resonance spectroscopy (Adcock et al., 2002).”
BackgroundCreatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration
Genius, J., Geiger, J., Bender, A., Möller, H.-J., Klopstock, T., & Rujescu, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030554 · Cited by 51
“The protective potential of creatine (1-methyl-guanidino acetic acid) has been extensively assessed in various models of neurodegeneration, including in vivo models of oxidative stress [1,2].”
BackgroundBalestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P. (2016) · Amino Acids · doi:10.1007/s00726-016-2173-8 · Cited by 60
Wallimann, T., Hall, C., Colgan, S., & Glover, L. (2021) · Nutrients · doi:10.3390/nu13051429 · Cited by 47
“Creatine also leads to a significant increase in cell survival after hypoxic insult in vivo [19,20,28].”
BackgroundSelf-citationO'Brien, F. E., Iwata, O., Thornton, J. S., Vita, E. D., Sellwood, M., Iwata, S., Sakata, Y. S., Charman, S. C., Ordidge, R. J., Cady, E. B., et al. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1649 · Cited by 56
Iwata, O., Iwata, S., Bainbridge, A. P., Vita, E. D., Matsuishi, T., Cady, E. B., & Robertson, N. J. (2008) · Brain · doi:10.1093/brain/awn150 · Cited by 51
“are potent neuroprotective treatments, induce an elevation in cerebral PCr (Wilken et al., 1998; Adcock et al., 2002; Erecinska et al., 2003).”
BackgroundTargeting cellular energy production in neurological disorders
Baker, S. K., & Tarnopolsky, M. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.10.1655 · Cited by 43
Hota, S. K., Barhwal, K. K., Singh, S. B., & Ilavazhagan, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.030 · Cited by 45
“ischemic stress indicating involvement of other complex molecular mechanisms that might lead to neural degeneration in hypobaric hypoxia (Adcock et al., 2002).”
Therapeutic use of creatine in brain or heart ischemia: Available data and future perspectives
Perasso, L., Spallarossa, P., Gandolfo, C., Ruggeri, P., & Balestrino, M. (2013) · Medicinal Research Reviews · doi:10.1002/med.20255 · Cited by 43
“In addition, several reports show that Cr is effective as a prophylactic treatment against neonatal hypoxic–ischemic encephalopathy.(75,77,177) In rodents, it has been demonstrated that administration of Cr to the pregnant mother results in elevation of Cr content in the fetal brain and that the latter is neuroprotect…”
BackgroundCreatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
Self-citationJuravleva, E., Barbakadze, T., Mikeladze, D., & Kekelidze, T. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20291 · Cited by 41
“Cr neuroprotection has also been demonstrated in models of oxidative stress in vivo (Matthews et al., 1998; Adcock et al., 2002).”
BackgroundWang, Y., Cheung, P.-T., Shen, G. X., Wu, E. X., Cao, G., Bart, I., Wong, W. H. S., & Khong, P.-L. (2006) · PubMed · Cited by 41
Introduction – Creatine: Cheap Ergogenic Supplement with Great Potential for Health and Disease
Wallimann, T. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_1 · Cited by 40
Self-citationEllery, S. J., Walker, D. W., & Dickinson, H. (2016) · Amino Acids · doi:10.1007/s00726-016-2199-y · Cited by 39
“Similar benefits were observed in vivo with rat pups (Adcock et al. 2002).”
BackgroundSestili, P., Ambrogini, P., Barbieri, E., Sartini, S., Fimognari, C., Calcabrini, C., Diaz, A. R., Guescini, M., Polidori, E., Luchetti, F., et al. (2016) · Amino Acids · doi:10.1007/s00726-015-2161-4 · Cited by 35
“1998) and protect against ischemic/anoxic brain damage (Adcock et al. 2002) the most common case of clinical seizures in the newborn period and, to the best of our knowledge, there is no report indicating an association of the increased risk of seizure with increased brain Cr levels.”
BackgroundSilva, L. A., Tromm, C. B., Da Rosa, G., Bom, K., Luciano, T. F., Tuon, T., De Souza, C. T., & Pinho, R. A. (2013) · Journal of Sports Sciences · doi:10.1080/02640414.2013.773403 · Cited by 31
“Some studies demonstrated higher ATP and phosphocreatine tissue levels (Adcock et al., 2002, Wilken, Ramihk, Prohst, Richter, & Hanekeld, 2000), improved cerebral reperfusion, and reduced infarct size (Prass et al., 2006) after a hypoxia.”
BackgroundReyes‐Corral, M., Idígora, N. S., la Puerta, R. D., Montaner, J., & Ybot‐González, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052524 · Cited by 31
“injection ↓ Brain edema, ↑ energy potential and the levels of phosphocreatine in the brain [86]”
BackgroundResultBancila, M., Copin, J., Daali, Y., Schatlo, B., Gasche, Y., & Bijlenga, P. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00879.x · Cited by 28
Tran, N. T., Kelly, S. B., Snow, R. J., Walker, D. W., Ellery, S. J., & Galinsky, R. (2021) · Cells · doi:10.3390/cells10112902 · Cited by 27
“[18] P7, Sprague-Dawley rat; ? sex Right CAL, then 100 min of hypoxia (8% O2) 3 g/kg s.”
BackgroundMethodInfluentialWang, Y., Cheung, P., Shen, G. X., Bhatia, I., Wu, E. X., Qiu, D., & Khong, P. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.12.003 · Cited by 25
“…artery ligation, followed by systemic hypoxia (Albensi et al., 1999; Wagner et al., 2002; Balduini et al., 2001; Xia et al., 2005; Dingley et al., 2006; Shin et al., 2006; Tutak et al., 2005; Adcock et al., 2002; Jatana et al., 2006; Park et al., 2006; Feng et al., 2006; Nedelcu et al., 2000).”
BackgroundInfluentialEllery, S. J., Dickinson, H., McKenzie, M., & Walker, D. W. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.002 · Cited by 23
“Studies involving animal models of CNS injury and neurodegenerative disorders have also highlighted a neuroprotective capacity of increasing the neuronal pool of Cr/PCr via dietary creatine supplementation (Adcock et al., 2003; Prass et al., 2006; Andres et al., 2008).”
Feasibility and safety of passive cooling in a cohort of asphyxiated newborn infants
Daetwyler, K., Brotschi, B., Berger, T., & Wagner, B. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13767 · Cited by 22
Self-citationCreatine for women in pregnancy for neuroprotection of the fetus
Bain, E., Wilkinson, D., Middleton, P., Crowther, C. A., Dickinson, H., & Walker, D. W. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010846 · Cited by 19
Therapeutic potential of nutraceuticals to protect brain after stroke
Chelluboina, B., & Vemuganti, R. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104908 · Cited by 18
Turner, C. E., & Gant, N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401688-0.00007-0 · Cited by 18
Structural correlates of the creatine transporter function regulation: The undiscovered country
Santacruz, L., & Jacobs, D. O. (2016) · Amino Acids · doi:10.1007/s00726-016-2206-3 · Cited by 17
KONES, R. J. (2010) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s12082 · Cited by 13
“Similarly, creatine affords protection in mouse models of stroke.(55,56) In one study, creatine supplementation for three weeks followed by a 45-minute ligation of the middle cerebral artery reduced the amount of brain tissue lost by about 40%.”
Advanced MR brain imaging. Why?
Huisman, T. A. G. M., & Tekes, A. (2008) · Pediatric Radiology · doi:10.1007/s00247-008-0895-9 · Cited by 13
The role of nutrition in mild traumatic brain injury rehabilitation for service members and veterans
Monti, K. S., Conkright, M. W., Eagle, S. R., Lawrence, D. W., & Dretsch, L. M. (2024) · Neurorehabilitation · doi:10.3233/nre-230241 · Cited by 12
“Beneficialeffects,suchasbrainandspinal cordneuroprotectionandincreasedfunctional improvements,havebeenobservedbyproviding supplementalcreatinetorodentmodelswithTBI (Adcock et al., 2002; Sullivan et al., 2000).”
Repurposing of dexpramipexole to treatment of neonatal hypoxic/ischemic encephalopathy
Muzzi, M., Buonvicino, D., Urru, M., Tofani, L., & Chiarugi, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.064 · Cited by 11
Sports-Related Brain Injury and Neurodegeneration in Athletes
Dhote, V. V., Raja, M. K. M. M., Samundre, P., Sharma, S., Anwikar, S., & Upaganlawar, A. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210910114324 · Cited by 9
Berger, H. R., Brekke, E., Widerøe, M., & Morken, T. S. (2017) · Developmental Neuroscience · doi:10.1159/000472709 · Cited by 9
In Vivo Cerebral 31P Magnetic Resonance Spectroscopy
Cady, E. B. (2011) · Advances in neurobiology · doi:10.1007/978-1-4614-1788-0_6 · Cited by 9
Mácha, H., Luptáková, D., Juránek, I., Andrén, P. E., & Havlíček, V. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00190 · Cited by 8
Mitochondrial VDAC and Its Complexes
Brdiczka, D. G. (2007) · Wiley eBooks · doi:10.1002/9783527621095.ch6 · Cited by 8
Tran, N. T., Tran, J., Yawno, T., Snow, R. J., Walker, D. W., & Ellery, S. J. (2025) · Developmental Neuroscience · doi:10.1159/000544756 · Cited by 7
Andres, R. H., Ducray, A., Andereggen, L., Hohl, T., Schlattner, U., Wallimann, T., & Widmer, H. R. (2016) · Amino Acids · doi:10.1007/s00726-016-2238-8 · Cited by 7
“…(Andres et al. 2005c, b), Alzheimer's disease (Brewer and Wallimann 2000), amyotrophic lateral sclerosis (Klivenyi et al. 1999, 2004; Dupuis et al. 2004; Zhang et al. 2003), and ischemia (Prass et al. 2006; Berger et al. 2004; Adcock et al. 2002; Lensman et al. 2006), both in vitro and in vivo.”
BackgroundSelf-citationНерсесова, Л. С. (2011) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093011020034 · Cited by 7
“Cr facilitates the marked neuroprotection in experimental animal models in lateral amyotrophic sclerosis, Hantington’s disease, Parkinsonism, traumatic lesions of brain and spinal cord, cerebral ischemia [2, 5, 8, 56, 57].”
BackgroundPreventive, rescue and reparative neuroprotective strategies for the fetus and neonate
Lear, B. A., Zhou, K. Q., Dhillon, S. K., Lear, C. A., Bennet, L., & Gunn, A. J. (2024) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2024.101542 · Cited by 6
Petrosyan, M. S., Нерсесова, Л. С., Adamyan, N. A., Газарянц, М. Г., & Akopyan, Z. I. (2019) · Neurochemical Journal · doi:10.1134/s1819712419030115 · Cited by 6
Jain, V. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_16 · Cited by 5
Kalamitsou, S., Masino, S. A., Pavlou, E., Γώγου, Μ., Katsanika, I., Papadopoulou‐Legbelou, K., Serdari, A., Spilioti, M. G., & Evangeliou, A. (2019) · Integrative Molecular Medicine · doi:10.15761/imm.1000357 · Cited by 5
Creatine Amides: Perspectives for Neuroprotection
Vlasov, T. D., Чефу, С. Г., Baisa, A. E., Leko, M. V., Burov, S. V., & Веселкина, О. С. (2013) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-013-9756-6 · Cited by 4
“Experimental studies have demonstrated that creatine increases the formation of creatine phosphate in nerve cells and has significant neuroprotective actions in ischemic (hypoxic) damage to brain tissue [5].”
BackgroundAllahyar, R., & Iqbal, F. (2014) · Pakistan Journal of Zoology · Cited by 2
Vargas, N. S. O. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2012.tde-29082012-135124 · Cited by 2
Toniolo, R. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-07122016-150647 · Cited by 2
A METABOLIC APPROACH TO INVESTIGATE THE ROLE OF AMINO ACIDS IN BRAIN
Das, A. (2022) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/24407 · Cited by 2
Bury, A., Biesaga, P., Kotte, K., Jadanowski, O., Łebek, K., Sobota, W., Piskorz, P., Litworska-Sójka, D., Komsta, B., & Lipiec, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3546 · Cited by 1
Lehmeidi, Y., & Neto, T. B. (2025) · Cureus · doi:10.7759/cureus.90661 · Cited by 1
“In contrast, creatine helps maintain ATP-dependent calcium pumps and buffering systems [9].”
Chun, J., Babakhani, K., Gonzalez, D. E., Dickerson, B. L., Sowinski, R. J., Rasmussen, C. J., & Kreider, R. B. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2711032 · Cited by 2
Aspects of retinal energy metabolism.
Han, G. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Repair and Neuroprotective Strategies in Multiple Sclerosis
Dangond, F. (2005) · Humana Press eBooks · doi:10.1385/1-59259-855-2:193
“Creatine may work by maintaining energy metabolism (prevent energy failure), preventing calcium overload, counteracting mitochondrial permeability transition pore opening, enhancing cytoplasmic high-energy phosphates (103), and exerting antioxidant effects ( 104 ).”
BackgroundEffect of Creatine on the Survival of RGC-5 Cells under Serum Deprivation
Kim, J. W., Hong, J. H., Kang, S. H., & Kim, Y. Y. (2011) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2011.52.5.618
Nitrogenous Compounds and Supplements
Landis, J. A., Ziegenfuss, T. N., & Lopez, H. L. (2012) · CRC Press eBooks · doi:10.1201/b11928-10
O envolvimento de proteínas quinases na facilitação do aprendizado espacial induzido por creatina
Souza, M. A. (2009) · Americanae (AECID Library)
Gandhi, S., Koundal, S., Kaur, T., Khushu, S., & Singh, A. K. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.026
RetractedA Review Of Creatine And Its Role In Muscle Strength And Balance
Albl, A. A. (2018) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · doi:10.71889/5fylantbak.29862935
Condeço, M. G. G. D. S. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Saturation Transfer Neuroimaging Features of Sickle Cell Anemia
Skarsgard, M. (2020) · TSpace (University of Toronto)
Estudos sobre a eficácia terapêutica da suplementação de creatina
Gualano, B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.39.2021.tde-08112021-101257
Greenwood, M., Leutholtz, B., & Kreider, R. B. (2004) · CRC Press eBooks · doi:10.1201/9780203507704.ch6
Quantification of tissue creatine content using capillary electrophoresisPreprint
Choi, Y. J., Bautista, A. P. R., Terrill, J. R., Pillow, J. J., & Arthur, P. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.09.588648
“In a research context, similar HPLC methods are used to assess creatine content in tissue or cell culture samples [14–16] or 31 P-magnetic resonance spectroscopy (MRS) to quantify high-energy phosphates in the brain tissue [17].”
MethodVIANA, C. J., VIANA, B. C. L., & COSTA, E. C. D. M. (2024) · Editora Científica Digital eBooks · doi:10.37885/240716999
Metadata
- Authors
- Adcock, K. H., Nedelcu, J., Loenneker, T., Martin, E., Wallimann, T., & Wagner, B. P.
- Affiliations
- University Children's Hospital Zurich (CH)
- ETH Zurich (CH)
- University Children’s Hospital Bern (CH)
- ORCID
- Wallimann, Theo
- Venue
- Developmental Neuroscience
- Publisher
- S. Karger AG
- Published
- 2002
- Volume
- 24
- Issue
- 5
- Pages
- 382-388
- ISSN
- 0378-5866 (ISSN-L)
- 1421-9859
- OpenAlex
- W2002511861
- Cited by
- 97
- References
- 56
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2021: 8 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Developmental Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- creatine supplementation, neuroprotection, neonatal brain injury, cerebral edema, energy metabolism, phosphocreatine, 31P NMR, diffusion-weighted imaging, carotid artery ligation, calcium overload, mitochondrial permeability transition pore, antioxidant activity
- MeSH terms
- Animals, Animals, Newborn, Brain Edema, Creatine, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Radiography, Telencephalon, Rats, Sprague-Dawley, Neuroprotective Agents, Hypoxia-Ischemia, Brain, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.